Reply to letters regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

John W. Eikelboom, Stuart J. Connolly, Jeff S. Healey, Sean Yang, Salim Yusuf, Lars Wallentin, Jonas Oldgren, Mike Ezekowitz, Marco Alings, Scott Kaatz, Stefan H. Hohnloser, Hans Christoph Diener, Maria Grazia Franzosi, Kurt Huber, Paul Reilly, Jeanne Varrone

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Issue number3
Publication statusPublished - Jan 24 2012

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this